DZ1124A1 - Tricyclic compounds. - Google Patents

Tricyclic compounds.

Info

Publication number
DZ1124A1
DZ1124A1 DZ870149A DZ870149A DZ1124A1 DZ 1124 A1 DZ1124 A1 DZ 1124A1 DZ 870149 A DZ870149 A DZ 870149A DZ 870149 A DZ870149 A DZ 870149A DZ 1124 A1 DZ1124 A1 DZ 1124A1
Authority
DZ
Algeria
Prior art keywords
tricyclic compounds
tricyclic
compounds
Prior art date
Application number
DZ870149A
Other languages
French (fr)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DZ1124A1 publication Critical patent/DZ1124A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/58Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DZ870149A 1986-09-12 1987-09-09 Tricyclic compounds. DZ1124A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP86112619 1986-09-12

Publications (1)

Publication Number Publication Date
DZ1124A1 true DZ1124A1 (en) 2004-09-13

Family

ID=8195410

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ870149A DZ1124A1 (en) 1986-09-12 1987-09-09 Tricyclic compounds.

Country Status (22)

Country Link
JP (3) JPH0696578B2 (en)
KR (1) KR960002857B1 (en)
CN (1) CN1017800B (en)
AT (1) AT389119B (en)
AU (1) AU602534B2 (en)
CA (1) CA1336905C (en)
CZ (1) CZ281195B6 (en)
DK (1) DK173330B1 (en)
DZ (1) DZ1124A1 (en)
FI (1) FI86428C (en)
HU (1) HU199481B (en)
IE (1) IE61624B1 (en)
IL (1) IL83814A (en)
MC (1) MC1850A1 (en)
MX (1) MX8302A (en)
NO (1) NO169125C (en)
NZ (1) NZ221681A (en)
PH (1) PH23930A (en)
PT (1) PT85686B (en)
SK (1) SK660487A3 (en)
ZA (1) ZA876636B (en)
ZW (1) ZW16387A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW16387A1 (en) * 1986-09-12 1988-05-25 Hoffmann La Roche Tricyclic compounds
JP4820290B2 (en) * 2004-05-13 2011-11-24 第一三共株式会社 Substituted pyrrolidine derivatives
US7563805B2 (en) * 2005-05-19 2009-07-21 Daiichi Pharmaceutical Co., Ltd. Tri-, tetra-substituted-3-aminopyrrolidine derivative
AU2007225088B2 (en) 2006-03-13 2012-09-13 Kyorin Pharmaceutical Co., Ltd Aminoquinolones as GSK-3 inhibitors
CN101855228B (en) 2007-09-11 2012-10-24 杏林制药株式会社 Cyanoaminoquinolones and tetrazoloaminoquinolones as GSK-3 inhibitors
CA2699152C (en) 2007-09-12 2015-11-24 Activx Biosciences, Inc. Spirocyclic aminoquinolones as gsk-3 inhibitors
FR2928150A1 (en) * 2008-02-29 2009-09-04 Vetoquinol Sa Sa NOVEL 7-SUBSTITUTED 3-CARBOXY-OXADIAZINO-QUINOLONES DERIVATIVES, THEIR PREPARATION AND APPLICATION AS ANTI-BACTERIANS
EP2145891A1 (en) * 2008-07-09 2010-01-20 Vetoquinol S.A. 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
EP2406266B1 (en) 2009-03-11 2013-12-25 Kyorin Pharmaceutical Co., Ltd. 7-cycloalkylaminoquinolones as gsk-3 inhibitors
CN107522718B (en) * 2017-09-14 2019-11-08 浙江国邦药业有限公司 A kind of synthetic method of Marbofloxacin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW16387A1 (en) * 1986-09-12 1988-05-25 Hoffmann La Roche Tricyclic compounds

Also Published As

Publication number Publication date
NO873816L (en) 1988-03-14
PT85686A (en) 1987-10-01
IE61624B1 (en) 1994-11-16
CA1336905C (en) 1995-09-05
JPH0819120B2 (en) 1996-02-28
PH23930A (en) 1990-01-23
FI86428C (en) 1992-08-25
AT389119B (en) 1989-10-25
DK173330B1 (en) 2000-07-24
HUT47294A (en) 1989-02-28
JPH0696578B2 (en) 1994-11-30
KR960002857B1 (en) 1996-02-27
JPS63132891A (en) 1988-06-04
KR880003954A (en) 1988-06-01
DK477287D0 (en) 1987-09-11
MC1850A1 (en) 1988-09-30
AU7811487A (en) 1988-03-17
NO873816D0 (en) 1987-09-11
ZW16387A1 (en) 1988-05-25
ATA263887A (en) 1989-03-15
NZ221681A (en) 1990-12-21
AU602534B2 (en) 1990-10-18
SK278990B6 (en) 1998-05-06
FI873940A0 (en) 1987-09-11
PT85686B (en) 1990-05-31
HU199481B (en) 1990-02-28
CN87106838A (en) 1988-05-11
FI86428B (en) 1992-05-15
ZA876636B (en) 1988-07-27
NO169125B (en) 1992-02-03
JPH07138262A (en) 1995-05-30
MX8302A (en) 1993-12-01
SK660487A3 (en) 1998-05-06
CN1017800B (en) 1992-08-12
FI873940A (en) 1988-03-13
DK477287A (en) 1988-03-13
CZ281195B6 (en) 1996-07-17
IE872444L (en) 1988-03-12
JPH07138256A (en) 1995-05-30
IL83814A (en) 1991-09-16
JPH0826030B2 (en) 1996-03-13
CZ660487A3 (en) 1996-04-17
NO169125C (en) 1992-05-13

Similar Documents

Publication Publication Date Title
ES2019932B3 (en) MACROLID COMPOUNDS.
MX9202732A (en) SUBSTITUTED PHENOLS.
ATE74920T1 (en) SUBSTITUTED INDOLOQUINOXALINES.
FI880545A (en) HUV FOER TOILETSTOL.
DE3764006D1 (en) SUBSTITUTED AMINOXYPROPANOATE.
DZ1124A1 (en) Tricyclic compounds.
FI865073A0 (en) FOERFARANDE FOER ELIMINERING AV MIKROBER I PROCESSVATTEN AV PAPPERSFABRIKER.
FI860738A (en) TRICYCLIC FOERENINGAR.
DE3766279D1 (en) SUBSTITUTED AMINOXYPROPIONAMIDES.
FI860669A0 (en) SPETSLIST I INLOPPSLAODAN AV EN PAPPERSMASKIN.
DE3784530D1 (en) DICYANOBENZANTHRON COMPOUNDS.
FI874159A (en) ANORDING FOR TILLVERKNING AV RINGFORMIGA POLYMERARTIKLAR.
DE3670078D1 (en) R-1-CYAN-1-R2 -CIS-4-R1 -CYCLOHEXAN COMPOUNDS.
NO870578L (en) AMINOACYLOKSYMETYL COMPOUNDS.
FI852975A0 (en) TRICYCLIC KINOLINDERIVAT.
ATE58539T1 (en) SUBSTITUTED PYRIMIDOINDOLS.
FI77942B (en) ANORDNING FOER STABILIZERING AV MAETNINGSGEOMETRI I EN ANALYSATOR.
DE3751570D1 (en) Difluoro-peptide compounds.
OA08616A (en) Substituted 4-benzyl-piperazinyl compounds.
FI871439A0 (en) ANORDING FOR TOEMNING AV BEHAOLLARE.
DK355787D0 (en) TRICYCLIC COMPOUNDS
FI865275A0 (en) ANORDINATION FOR HAOLLNING AV BILDROERSPANEL.
FI874931A0 (en) ANVAENDNING AV ALFA-2I-SELECTIVE ADRENERIC RECEPTORAGONISTER FOR FOERBAETTRANDE AV MINNET.
FI863514A0 (en) FOERFARANDE FOER GOERANDE AV FINGERSKARVAR I VIRKESSTYCKEN.
FI860065A (en) FOERFARANDE FOER FASTSVETSNING AV EN STOEDPROFIL I EN MELLANVAEGG.